BillionToOne: Northstar Liquid Biopsies

BillionToOne launched its Northstar Response and Northstar Select liquid biopsy assays for commercial use in patients with late-stage solid tumors.

Northstar Select is an 81-gene pan-cancer somatic mutation profiling panel and Northstar Response is a methylation-based, tissue-agnostic treatment response monitoring assay. Both employ BillionToOne's proprietary molecular counting technology, called Quantitative Counting Templates, designed to enable a low limit of detection for identifying actionable alterations.